These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

233 related articles for article (PubMed ID: 28758274)

  • 1. Pregnancy and infant outcomes including major congenital malformations among women with chronic inflammatory arthritis or psoriasis, with and without etanercept use.
    Carman WJ; Accortt NA; Anthony MS; Iles J; Enger C
    Pharmacoepidemiol Drug Saf; 2017 Sep; 26(9):1109-1118. PubMed ID: 28758274
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Use of tumor necrosis factor-alpha inhibitors during pregnancy among women who delivered live born infants.
    Eworuke E; Panucci G; Goulding M; Neuner R; Toh S
    Pharmacoepidemiol Drug Saf; 2019 Mar; 28(3):296-304. PubMed ID: 30430682
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Incidence Rates of Psoriasis in Children With Inflammatory Bowel Disease and Juvenile Arthritis Treated With Tumor Necrosis Factor Inhibitors and Disease-Modifying Antirheumatic Drugs.
    Baggett K; Brandon TG; Xiao R; Valenzuela Z; Buckley LH; Weiss PF
    J Rheumatol; 2022 Aug; 49(8):935-941. PubMed ID: 35428721
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Congenital malformations in infants exposed to antiepileptic medications in utero at Boston Medical Center from 2003 to 2010.
    Deck GM; Nadkarni N; Montouris GD; Lovett A
    Epilepsy Behav; 2015 Oct; 51():166-9. PubMed ID: 26283306
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Pregnancy outcome following prenatal exposure to triptan medications: a meta-analysis.
    Marchenko A; Etwel F; Olutunfese O; Nickel C; Koren G; Nulman I
    Headache; 2015 Apr; 55(4):490-501. PubMed ID: 25644494
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Drug discontinuation in pregnant women with psoriasis: The PSO-MOTHER cohort study.
    Belleudi V; Poggi FR; Perna S; Naldi L; Bortolus R; Rosa AC; Kirchmayer U; Davoli M; Addis A
    Pharmacoepidemiol Drug Saf; 2020 Aug; 29(8):904-912. PubMed ID: 32501653
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Long-term Management of Moderate to Severe Plaque Psoriasis Patients With Etanercept: A Case Series.
    Bourcier M; Papp KA; Gulliver WP; Poulin Y; Barber K; Poulin-Costello M; Shelton J
    J Cutan Med Surg; 2015; 19(6):561-9. PubMed ID: 25951825
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Risk of Inflammatory Bowel Disease in Patients With Psoriasis and Psoriatic Arthritis/Ankylosing Spondylitis Initiating Interleukin-17 Inhibitors: A Nationwide Population-Based Study Using the French National Health Data System.
    Penso L; Bergqvist C; Meyer A; Herlemont P; Weill A; Zureik M; Dray-Spira R; Sbidian E
    Arthritis Rheumatol; 2022 Feb; 74(2):244-252. PubMed ID: 34279061
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Serious Infections in Rheumatoid Arthritis Offspring Exposed to Tumor Necrosis Factor Inhibitors: A Cohort Study.
    Vinet É; De Moura C; Pineau CA; Abrahamowicz M; Curtis JR; Bernatsky S
    Arthritis Rheumatol; 2018 Oct; 70(10):1565-1571. PubMed ID: 29771477
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Risk of adverse birth outcomes after maternal varenicline use: A population-based observational study in Denmark and Sweden.
    Pedersen L; Petronis KR; Nørgaard M; Mo J; Frøslev T; Stephansson O; Granath F; Kieler H; Sørensen HT
    Pharmacoepidemiol Drug Saf; 2020 Jan; 29(1):94-102. PubMed ID: 31713302
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Etanercept-Methotrexate Combination Therapy Initiators Have Greater Adherence and Persistence Than Triple Therapy Initiators With Rheumatoid Arthritis.
    Bonafede M; Johnson BH; Tang DH; Shah N; Harrison DJ; Collier DH
    Arthritis Care Res (Hoboken); 2015 Dec; 67(12):1656-63. PubMed ID: 26097194
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Anti-TNF treatment during pregnancy and birth outcomes: A population-based study from Denmark, Finland, and Sweden.
    Bröms G; Kieler H; Ekbom A; Gissler M; Hellgren K; Lahesmaa-Korpinen AM; Pedersen L; Schmitt-Egenolf M; Sørensen HT; Granath F
    Pharmacoepidemiol Drug Saf; 2020 Mar; 29(3):316-327. PubMed ID: 32020767
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Pregnancy and Infant Outcomes After Prenatal Exposure to Golimumab in Denmark, Finland, and Sweden 2006-2019.
    Karlsson P; Gembert K; Esslinger S; Geldhof A; Gissler M; Leinonen MK; Otero-Lobato M; Pedersen L; Cesta CE
    Pharmacoepidemiol Drug Saf; 2024 Aug; 33(8):e5878. PubMed ID: 39090766
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Treatment of graves' disease with antithyroid drugs in the first trimester of pregnancy and the prevalence of congenital malformation.
    Yoshihara A; Noh J; Yamaguchi T; Ohye H; Sato S; Sekiya K; Kosuga Y; Suzuki M; Matsumoto M; Kunii Y; Watanabe N; Mukasa K; Ito K; Ito K
    J Clin Endocrinol Metab; 2012 Jul; 97(7):2396-403. PubMed ID: 22547422
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Birth outcomes in women who have taken adalimumab in pregnancy: A prospective cohort study.
    Chambers CD; Johnson DL; Xu R; Luo Y; Lopez-Jimenez J; Adam MP; Braddock SR; Robinson LK; Vaux K; Lyons Jones K;
    PLoS One; 2019; 14(10):e0223603. PubMed ID: 31626646
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Use of biologics during pregnancy and risk of serious infections in the mother and baby: a Canadian population-based cohort study.
    Tsao NW; Lynd LD; Sayre EC; Sadatsafavi M; Hanley G; De Vera MA
    BMJ Open; 2019 Feb; 9(2):e023714. PubMed ID: 30787081
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Impact of Etanercept Therapy on Disease Activity and Health-Related Quality of Life in Moderate Rheumatoid Arthritis Patients Population from a National British Observational Cohort.
    Kotak S; Mardekian J; Horowicz-Mehler N; Shah A; Burgess A; Kim J; Gemmen E; Boyd H; Koenig A
    Value Health; 2015 Sep; 18(6):817-23. PubMed ID: 26409609
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Birth outcomes in women who have taken leflunomide during pregnancy.
    Chambers CD; Johnson DL; Robinson LK; Braddock SR; Xu R; Lopez-Jimenez J; Mirrasoul N; Salas E; Luo YJ; Jin S; Jones KL;
    Arthritis Rheum; 2010 May; 62(5):1494-503. PubMed ID: 20131283
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Medication effectiveness with the use of tumor necrosis factor inhibitors among Texas Medicaid patients diagnosed with rheumatoid arthritis.
    Oladapo A; Barner JC; Lawson KA; Novak S; Rascati KL; Richards KM; Harrison DJ
    J Manag Care Spec Pharm; 2014 Jul; 20(7):657-67. PubMed ID: 24967519
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Use of antidepressant medication in pregnancy and adverse neonatal outcomes: A population-based investigation.
    Cantarutti A; Merlino L; Giaquinto C; Corrao G
    Pharmacoepidemiol Drug Saf; 2017 Sep; 26(9):1100-1108. PubMed ID: 28594145
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 12.